Percutaneous absorption of captorpil from hydrophilic cellulose gel® through excised rabbit skin and human skin

International Journal of Pharmaceutics

Volumn 145, Issue 1-2, 1996, Pages 215-220

  Wu, Pao Chu ^a   Huang, Yaw Bin ^a   Lin, Hung Hong ^a   Tsai, Yi Hung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Captopril; Human skin; Minimum effective concentration; Percutaneous absorption; Required flux; Saturated fatty acid

Indexed keywords

CAPTOPRIL; CELLULOSE; DECANOIC ACID; LAURIC ACID; MYRISTIC ACID; SATURATED FATTY ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RELEASE; GEL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RABBIT; SKIN ABSORPTION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030573080     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04773-4     Document Type: Article

References (14)

1. Aungst, B., Rogers, N.J.J. and Shefter, E., Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, sufactants, sulfoxides and amindes. Int. J. Pharm., 33 (1986) 225-234.
2. Chien, Y.W., Novel Drug Delivery Systems. Marcel Dekker, New York, 1992.
3. Chowhan, Z.T. and Pritchard, R., Effect of surfactants on percutaneous absorption of naproxen I: comparisons of rabbit, rat, and human excised skin. J. Pharm. Sci., 67 (1978) 1272-1274.
4. Fang, J.Y., Wu, P.C., Huang, Y.B. and Tasi, Y.H., Percutaneous absorption of capsacin, nonivamide and sodium nonivamide acetate from gel and ointment bases: in vitro formulation evaluations in pigs and in vivo bioengineering method in humans. Int. J. Pharm., 130 (1996) 121-135.
5. Huang, Y.B., Wu, P.C., Ko, H.M. and Tsai, Y.H., Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenac. Int. J. Pharm., 126 (1995) 111-117.
6. Jarrott, B., Drummer. O., Hooper, R., Anderson, A.I.E., Miach, P.J. and Louis, W.J., Pharmacokinetic properties of captopril after acute and chronic administration to hypertensive subjects. Am. J. Cardiol., 49 (1982) 1547.
7. Keshary, P.R. and Chien, Y.W., Mechanism of transdermal controlled nitroglycerin administration: development of a finite-dosing skin permeation system. Drug Dev. Ind. Pharm., 10 (1984) 883-913.
8. Kobayashi, D., Matsuzawa, T., Sugibayashi, K., Morimoto, Y., Kobayashi, M., and Kimura, M., Feasibility of use of several cardiovascular agents in transdermal therapeutic system with 1-menthol-ethanol system on hairless rat and human skin. Biol. Pharm. Bull., 16 (1995) 254-258.
9. Komata, Y., Inaoka, M., Kaneko, A. and Fujie, T., In vitro percutaneous absorption of thiamine disulfide from a mixture of propylene glycol and fatty acid. J. Pharm. Sci., 81 (1992) 744-746.
10. Kydonieus, A., Treatise on Controlled Drug Delivery, Marcel Dekker, New York, 1992.
11. Levy, M., Koren, G., Klein, J., McLorie, G. and Balfe, J.W., Captopril pharmaco-kinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. Dev. Pharmacol. Ther., 4 (1991) 185-193.
12. Raia, J.J., Toseph, J., Barone, J.A., Byerly, W.B. and Lacy, C.R., Angiotensin converting enzyme inhibitor: a comparative review. DICP Ann. Pharmacother., 24 (1990) 506-511.
13. Wu, P.C., Hung, Y.B., Lin, H.H. and Tsai, Y.H., In vitro percutaneous absorption of captoprit through excised rabbit skin., Int. J. Pharm., 00 (1996) 00.
14. Zhou, X.H. and Li Wan Po, A., Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine. Biochem. Pharmacol., 47 (1994) 1121-1126.